Several disease-modifying therapies for MS were associated with increased risks for urinary tract infections and urosepsis, ...

Drugs called interferon betas are common treatments for multiple sclerosis (MS), reducing relapses and slowing motor function decline. Interferon beta, a protein known to contain a zinc binding pocket ...

A new study found extensive alternative splicing of messenger RNA in the blood cells of untreated multiple sclerosis patients compared to healthy controls. The study, which showed that highly ...

Pegylated interferon beta-1a (Plegridy) was separated from the MTA of beta interferons and glatiramer acetate for treating multiple sclerosis because a separate single technology appraisal for this ...

Amid the coronavirus disease (COVID-19) pandemic, scientists and health experts race to develop drugs and vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Many ...

Results of an innovative clinical trial led by Perth researchers have shown that the drug interferon could help reduce the spread of COVID-19 from a positive person to their household contacts, with ...

Following the Appraisal Committee meeting on this for ‘Beta interferons and glatiramer acetate for treating multiple sclerosis [ID809]’ on 23 May, we are pausing this appraisal. From discussions with ...